Hi BC Good comments. When I said faith I probably should...

Hi BC

Good comments. When I said faith I probably should clarify, I really meant faith in your own analysis and judgement as an investor of whether the company has a good product and will successfully grow shareholder value for you in the long term. You may be able to tell from my posts that I can be sceptical of company claims so I would never place faith in what company management tells shareholders ("trust but validate" is a saying I heard a long time ago and have adopted as a credo I subscribe to, and that was reinforced when I learnt the hard way in my early investing days).

The volumes changing hands at these levels are low (today is above average) so I agree we are probably seeing a few "weak hands" getting nervous. The important thing at this point is the CR is completed successfully to secure funding for the next stage of Protean commercialisation. It is always unfortunate that CR's have a temporary impact on company SP, but CR's are useful I believe as a periodic validation of business valuation (new investors wouldn't inject funds at the CR price if they didn't see the value/potential) - and they provide vital new funds for future growth (if deployed effectively)!

Cheers, Sharks.